Senior author and McMaster University immunologist Dawn Bowdish says the study results are surprising because they challenge the current thinking about hybrid immunity.
Doctors have been calling for an RSV vaccine for seniors because although the virus is common, older people are much more likely to become severely ill and require hospitalization.
